The Global Vulvovaginal Candidiasis Treatment Market is Predict to reach $1.3 Billion by 2028, at a CAGR of 4.6%

Published Date: 30-Nov-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Vulvovaginal Candidiasis Treatment Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Vulvovaginal Candidiasis Treatment Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 4.6% CAGR during the forecast period.

The Online Pharmacy market is experiencing a CAGR of 5.6% during (2022 - 2028). A vast proportion of patients prefer online pharmacy instead of choosing to go to offline pharmacy stores. Furthermore, the emergence of various online pharmacy stores, such as Netmeds, is further supporting the sale of VVC treatment drugs through online stores, thereby contributing to the market expansion.

The Oral market is leading the segment in the Global Vulvovaginal Candidiasis Treatment Market by Route of Administration in 2021; thereby, achieving a market value of $582.8 million by 2028. This is due to the convenience of this route of administration for azoles, high availability, and utilization of anti-fungal drugs. In addition, oral fluconazole is the drug used most for prescription drugs recommended for treatment in maintenance therapy.

The Clotrimazole market is registering a CAGR of 5.1% during (2022 - 2028). The growth is the result of unremarkable side effects and an uncomplicated metabolic profile, and clotrimazole has gained traction for the treatment of infections such as vulvovaginal candidiasis. Further, the clotrimazole drug has undergone various research-related activities, resulting in its rising popularity.

The North America market dominated the Global Vulvovaginal Candidiasis Treatment Market by Region in 2021; thereby, achieving a market value of $479.2 million by 2028. The Europe market is poised to grow at a CAGR of 4.2% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 5.3% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/vulvovaginal-candidiasis-treatment-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, Bristol Myers Squibb Company, Pfizer, Inc., Astellas Pharma, Inc., Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC), Basilea Pharmaceutica Ltd., Scynexis, Inc. and Grupo Ferrer Internacional S.A.

Global Vulvovaginal Candidiasis Treatment Market Segmentation

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Route of Administration

  • Oral
  • Intravenous
  • Topical

By Drug Class

  • Fluconazole
  • Clotrimazole
  • Terconazole
  • Terbinafine
  • Nystatin
  • Ketoconazole
  • Others
  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bayer AG
  • Bristol Myers Squibb Company
  • Pfizer, Inc.
  • Astellas Pharma, Inc.
  • Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC)
  • Basilea Pharmaceutica Ltd.
  • Scynexis, Inc.
  • Grupo Ferrer Internacional S.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Vulvovaginal Candidiasis Treatment Market Future Scope & Opportunities 2022-2028

Europe Vulvovaginal Candidiasis Treatment Market Size & Growth Forecast 2022-2028

Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Outlook to 2028

LAMEA Vulvovaginal Candidiasis Treatment Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.